Thrive | Considering CAR T-Cell Therapy for Myeloma? What You Should Know

Empowered!
20/03/2024 35 min Temporada 3 Episodio 4
Thrive | Considering CAR T-Cell Therapy for Myeloma? What You Should Know

Listen "Thrive | Considering CAR T-Cell Therapy for Myeloma? What You Should Know"

Descargar episodio

Episode Synopsis

Dr. Beth Faiman, a myeloma expert and researcher, discusses factors that should be considered when deciding to undergo CAR T-cell therapy, advice for preparing for and after the process, and why a good support team is essential. Dr. Faiman also shares research updates in CAR T-cell therapy, and alternatives options to this myeloma treatment.Dr. Beth Faiman is an Adult Nurse Practitioner in the department of Hematologic Oncology and Blood Disorders at the Cleveland Clinic. Learn more about Dr. Faiman.See More From Thrive CAR T-Cell TherapyDownload Resource Guide

More episodes of the podcast Empowered!

Empowering Providers to Close Gaps in Prostate Cancer Care 01/10/2025
How AI Is Shaping the Future of Personalized and Proactive Cancer Care 20/08/2025
Understanding Artificial Intelligence and Its Direct Impact on Cancer Care 06/08/2025
Myeloma Patient Expert Q&A: Dr. Ola Landgren 22/05/2024
Evolving Myeloma Treatment Options: How You Can Access Cutting-Edge Care 15/05/2024
Evolving Myelofibrosis Treatment Options: What You Should Know 24/04/2024
Kidney Cancer Patient Expert Q&A: Dr. Moshe Ornstein 17/04/2024
Myeloma Patient Expert Q&A: Dr. Sikander Ailawadhi 10/04/2024
Head & Neck Cancer: What Do You Need to Know About Evolving Treatment and Research? 03/04/2024
HCP Roundtable: Critical Clinical Trial Conversations in the Expanding Myeloma Landscape 13/03/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA